Latest News

OEHHA announced the end of the public comment period on the draft document, Prioritization of Toxic Air Contaminants - Children's Environmental Health Protection Act.

The final technical support document for the Public Health Goal for benzene in drinking water is available.

John R. Froines, Ph.D. Announces Resignation from Carcinogen Identification Committee

Request for information on cyclohexanol, 2,4-DP  to be considered by OEHHA's Science Advisory Board's Developmental and Reproductive Toxicant (DART) Identification Committee for possible removal from the list and revision of the basis for inclusion on the list of chemicals known to the State to cause reproductive toxicity: 2,4-D Butyric Acid.

Chemical listed effective June 15, 2001 as known to the state to cause reproductive toxicity: N-methylpyrrolidone.

Proposal to establish specific regulatory levels posing no significant risk for chloroethane; di(2-ethylhexyl)phthalate (DEHP); lead; lead acetate; lead phosphate; lead subacetate; methylhydrazine; methylhydrazine sulfate; 5-morpholinomethyl-3-[(5-nitrofurfurylidene)-amino]-2-oxazolidinone; MX (3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone); phenylhydrazine; phenylhydrazine hydrochloride; polygeenan; carbazole; MeIQ (2-amino-3,4-dimethylimidazo[4,5-f]quinoline); MeIQx(2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline); methyl carbamate; 4-(N-nitrosomethylamino)-1-(3-pyridyl)-1-butanone; and trimethyl phosphate

OEHHA recommends an action level of 330 ppb (ug/L) for both 1,2,4-trimethylbenzene and 1,3,5-trimethylbenzene in drinking water.

A fact sheet was prepared by OEHHA and the American Lung Association (ALAC) regarding health hazards associated with diesel exhaust.

Scientists with expertise in risk assessment was convened to conduct external peer review of risk assessment practices in the boards, departments and offices (BDOs) comprising the California Environmental Protection Agency (Cal/EPA).

OEHHA has provided a number of comments on the risk characterization methodology and conclusions on the draft RCD for Atrazine. These comments and our recommendations, as well as suggested clarifications, additions and corrections, are contained in this report.